Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Grabowski

Clinical Genetics (M.D.) Cincinnati, OH Medical Doctor

NPI 1174547806 CMS profile 510574

3333 Burnet Ave, Ml 4006, Cincinnati, OH 45229

Open in the dashboard

General payments

$123,199

86 records reported · program years 2019–2025

Research payments

$11,945

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Grabowski of Cincinnati, OH is reported in the CMS Open Payments database as having received $123,199 across 86 general payments and $11,945 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,458 21
2024 General $7,738 14
2023 General $16,600 22
2022 General $4,938 4
2022 Research $9,133 9
2021 General $10,999 7
2021 Research $2,813 2
2020 General $10,727 3
2019 General $65,741 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Grabowski
  • Clinical Genetics (M.D.) median
  • Middle half of Clinical Genetics (M.D.)
  • National median

In program year 2025, general payments to Gregory Grabowski were reported at $6,458. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.

Show as a table
Year Gregory Grabowski Clinical Genetics (M.D.) median Middle half National median
2019 $65,741 $130 $24–$2,691 $163
2020 $10,727 $126 $30–$3,700 $114
2021 $10,999 $185 $30–$3,777 $132
2022 $4,938 $136 $44–$2,749 $149
2023 $16,600 $196 $55–$5,220 $160
2024 $7,738 $165 $46–$3,171 $164
2025 $6,458 $255 $85–$3,583 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Shire North American Group Inc $32,510 8 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $27,007 12 payments
  3. Takeda Pharmaceutical Company, Limited $22,809 4 payments
  4. Moderna TX, Inc. $21,231 52 payments
  5. Regeneron Pharmaceuticals, Inc. $10,998 4 payments
  6. Genzyme Corporation $2,947 1 payment
  7. Biogen, Inc. $2,574 1 payment
  8. Kyowa Kirin, Inc. $1,250 2 payments
  9. Ipsen Bioscience Inc $1,225 1 payment
  10. Eli Lilly and Company $650 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $83,683 74 payments
  2. Travel and Lodging $33,017 10 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,480 1 payment
  4. Food and Beverage $19 1 payment
Products named General payments · program years 2019–2025
  1. VPRIV Genetic Disease $31,379 10 payments
  2. Vpriv Cardiovascular and Metabolic (CVM) $22,809 4 payments
  3. CEREZYME $2,947 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Moderna TX, Inc. $11,945 11 payments

Records

97 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Genetics (M.D.) in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record